P452: THE INTERACTOME OF CDK6 IN DIFFERENT ONCOGENIC CONTEXTS

P452: THE INTERACTOME OF CDK6 IN DIFFERENT ONCOGENIC CONTEXTS

Bibliographic Details
Main Authors:	L. Scheiblecker, S. Nebenfuehr, M. Zojer, E. Doma, V. Sexl, K. Kollmann
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000844696.20238.f9

Similar Items

CDK4/6 and MAPK—Crosstalk as Opportunity for Cancer Treatment
by: Lisa Scheiblecker, et al.
Published: (2020-11-01)

Cdk6: At the interface of Rb and p53
by: Sofie Nebenfuehr, et al.
Published: (2018-09-01)

CDK6 kinase inhibition unmasks metabolic dependencies in BCR::ABL1+ leukemia
by: Lisa Scheiblecker, et al.
Published: (2025-02-01)

Cdk6’s functions are critically regulated by its unique C-terminus
by: Alessia Schirripa, et al.
Published: (2025-02-01)

P325: A KINASE-DEAD VARIANT OF CDK6 IS ASSOCIATED WITH REDUCED TUMORIGENIC POTENTIAL AND A DISTINCT TRANSCRIPTIONAL REWIRING IN AN ALL MODEL
by: T. Klampfl, et al.
Published: (2022-06-01)

P453: CDK6 DEGRADATION IS IMPEDED BY P16INK4A AND P18INK4C IN AML
by: B. Schmalzbauer, et al.
Published: (2022-06-01)

P1407: CDK6 IN HEMATOPOIETIC STEM CELLS: MORE THAN A CELL CYCLE KINASE
by: I. Mayer, et al.
Published: (2022-06-01)

P1412: UNCOUPLING INK4 PROTEINS FROM CDK4/CDK6 IN HEMATOPOIETIC STEM CELLS
by: A. Schirripa, et al.
Published: (2022-06-01)

Inducible deletion of CDK4 and CDK6 – deciphering CDK4/6 inhibitor effects in the hematopoietic system
by: Barbara Maurer, et al.
Published: (2020-08-01)

CDK5: an oncogene or an anti-oncogene: location location location
by: Kumar Nikhil, et al.
Published: (2023-11-01)

P1310: A ROBUST APPROACH FOR THE GENERATION OF FUNCTIONAL HEMATOPOIETIC PROGENITOR CELL LINES TO MODEL LEUKEMIC TRANSFORMATION
by: E. Doma, et al.
Published: (2022-06-01)

Oncogenic TYK2 P760L kinase is effectively targeted by combinatorial TYK2, mTOR and CDK4/6 kinase blockade
by: Katharina Woess, et al.
Published: (2022-01-01)

Cdk6 contributes to cytoskeletal stability in erythroid cells
by: Iris Z. Uras, et al.
Published: (2017-06-01)

Integrated transcriptome interactome study of oncogenes and tumor suppressor genes in breast cancer
by: G. Pranavathiyani, et al.
Published: (2019-03-01)

The constitutional legitimacy of art. 452-quaterdecies, last co., c.p.and its relationship with art. 452-undecies of the Criminal Code
by: INGRAO Cristina
Published: (2020-04-01)

KDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastoma
by: Alexandra D’Oto, et al.
Published: (2021-12-01)

CDK10 in Gastrointestinal Cancers: Dual Roles as a Tumor Suppressor and Oncogene
by: Zainab A. Bazzi, et al.
Published: (2021-06-01)

P1273: INVESTIGATING THE ONCOGENIC POTENTIAL OF STAT5BN642H IN NK CELLS
by: K. Klein, et al.
Published: (2022-06-01)

JTP452 - Perhubungan Industri
by: PPJJ, Pusat Pengajian Jarak Jauh
Published: (2004)

EME 452 – Tribology (Tribologi)
by: Mekanik, Pusat Pengajian Kejuruteraan
Published: (2022)

JTP 452 - Perhubungan Industri
by: PPJJ, Pusat Pengajian Jarak Jauh
Published: (2004)

Linking Proteomic and Transcriptional Data through the Interactome and Epigenome Reveals a Map of Oncogene-induced Signaling
by: Huang, Shao-shan Carol, et al.
Published: (2013)

Linking proteomic and transcriptional data through the interactome and epigenome reveals a map of oncogene-induced signaling.
by: Shao-shan Carol Huang, et al.
Published: (2013-01-01)

T Cell-Intrinsic CDK6 Is Dispensable for Anti-Viral and Anti-Tumor Responses In Vivo
by: Klara Klein, et al.
Published: (2021-06-01)

Enzymes in the Cholesterol Synthesis Pathway: Interactomics in the Cancer Context
by: Pavel Ershov, et al.
Published: (2021-07-01)

Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex.
by: Ellis, M, et al.
Published: (1999)

Clinical CDK4/6 inhibitors induce selective and immediate dissociation of p21 from cyclin D-CDK4 to inhibit CDK2
by: Lindsey R. Pack, et al.
Published: (2021-06-01)

Phosphorylation of USP29 by CDK1 Governs TWIST1 Stability and Oncogenic Functions
by: Tangming Guan, et al.
Published: (2023-04-01)

Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancer
by: Abeer J. Al-Qasem, et al.
Published: (2022-09-01)

C. elegans Interactome; Human Binary Interactome; Rat Genome
by: K. Nybo, et al.
Published: (2008-11-01)

CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer
by: Chipumuro, Edmond, et al.
Published: (2017)

EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma
by: Antoni Andreu Martija, et al.
Published: (2023-11-01)

CDK5RAP3 is a co-factor for the oncogenic transcription factor STAT3
by: Susana P. Egusquiaguirre, et al.
Published: (2020-01-01)

INTERACTOMICS IN TRANSLATIONAL MEDICINE
by: A. I. Glukhov, et al.
Published: (2018-03-01)

The FBXW7‐NOTCH interactome: A ubiquitin proteasomal system‐induced crosstalk modulating oncogenic transformation in human tissues
by: Rohan Kar, et al.
Published: (2021-08-01)

CDK6 Immunophenotype Implicates Potential Therapeutic Application of CDK4/6 Inhibitors in Urothelial Carcinoma
by: Ran Sun, et al.
Published: (2022-04-01)

14.452 Economic Growth, Fall 2008
by: Acemoglu, Daron
Published: (2008)

14.452 Economic Growth, Fall 2009
by: Acemoglu, Daron
Published: (2017)

JTP452 - PERHUBUNGAN INDUSTRI APRIL 2004
by: PPJJ, Pusat Pengajian Jarak Jauh
Published: (2004)

JOW 452 - PERHUBUNGAN INDUSTRI APRIL 08
by: PPJJ, Pusat Pengajian Jarak Jauh
Published: (2008)